Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Beijing Tongrentang Co., Ltd.    600085   CNE000000R69

BEIJING TONGRENTANG CO., LTD.

(600085)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
09/09/2019 09/10/2019 09/11/2019 09/12/2019 09/16/2019 Date
28.26(c) 28.51(c) 28.19(c) 28.3(c) 28 Last
6 650 981 8 357 019 6 317 425 4 772 096 6 803 164 Volume
+0.25% +0.88% -1.12% +0.39% -1.06% Change
More quotes
Financials (CNY)
Sales 2019 15 021 M
EBIT 2019 2 350 M
Net income 2019 1 170 M
Finance 2019 6 791 M
Yield 2019 1,25%
Sales 2020 16 155 M
EBIT 2020 2 556 M
Net income 2020 1 272 M
Finance 2020 7 541 M
Yield 2020 1,27%
P/E ratio 2019 33,3x
P/E ratio 2020 30,5x
EV / Sales2019 2,13x
EV / Sales2020 1,94x
Capitalization 38 813 M
More Financials
Company
BEIJING TONGRENTANG CO., LTD is a China-based company principally engaged in the production and sales of traditional Chinese patent medicines. The Company’s main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and... 
Sector
Pharmaceuticals
Calendar
10/29Earnings Release
More about the company
Surperformance© ratings of Beijing Tongrentang Co., L
Trading Rating : Investor Rating :
More Ratings
Latest news on BEIJING TONGRENTANG CO., L
03/28As China pushes traditional medicine globally, illegal wildlife trade flouris..
RE
03/21BEIJING TONGRENTANG CO., LTD. : annual earnings release
2013CORRECTED-From street stalls to bourses, SE Asia's traditional medicine maker..
RE
More news
Analyst Recommendations on BEIJING TONGRENTANG CO., L
More recommendations
Sector news : Alternative Medicine
03:27aH LUNDBECK : Lundbeck buys Alder in $2 billion migraine treatment move
RE
02:48aA Plan to Fight Hep C -- WSJ
DJ
01:50aSANOFI : Abbott to Collaborate on Glucose Sensing, Insulin Delivery Data
DJ
09/14NOVARTIS : Trial and Error -2-
DJ
09/14NOVARTIS : Trial and Error
DJ
More sector news : Alternative Medicine
Chart BEIJING TONGRENTANG CO., LTD.
Duration : Period :
Beijing Tongrentang Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIJING TONGRENTANG CO., L
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 35,54  CNY
Last Close Price 28,30  CNY
Spread / Highest target 57,9%
Spread / Average Target 25,6%
Spread / Lowest Target -15,2%
EPS Revisions
Managers
NameTitle
Xiang Guang Liu General Manager & Director
Zhen Kun Gao Chairman
Bao Jian Ma Chairman-Supervisory Board
Hai Ou Gu Director
Zhi Mei Feng Director & Chief Accountant
Sector and Competitors
1st jan.Capitalization (M$)
BEIJING TONGRENTANG CO., LTD.2.91%5 484
CANOPY GROWTH CORP-4.21%9 547
AURORA CANNABIS INC14.31%6 105
CRONOS GROUP INC4.52%3 878
CURALEAF HOLDINGS INC51.86%3 513
DONG-E-E-JIAO CO LTD--.--%3 005